AUG 06, 2020 5:16 PM PDT

Identifying a Prognostic Biomarker for Neurological Deterioration After a Stroke

WRITTEN BY: Jasper Cantrell

Strokes are life-changing events that can cause a myriad of issues even after it is over. Plenty of tests, such as the national institute of health stroke scale (NIHSS), can gauge the severity of a stroke and predict the severity of the after-effects. Most of these tests use clinical indicators to generate prognosis, but no test utilizes biomarkers.

A team from the Seoul National University College of Medicine wanted to remedy that using the protein serum cardiac troponin 1. Troponin 1 is a protein involved in muscle contraction in the heart and is already a prognostic biomarker for heart attacks. The team specifically wanted to know if it could predict early neurological deterioration after a stroke.

Early neurological deterioration is when a patient experiences damage to neurological function after a stroke. To test this, they pulled data from over a thousand patients and examined several clinical and biological indicators, including troponin 1. Overall, they found that early neurological deterioration was associated with age, not using anti-coagulants, a high NIHSS score, and increased troponin levels. The NIHSS score is usually a good indicator of a good or poor prognosis after stroke. Further analysis showed that troponin levels and NIHSS scores were positively associated, giving more support for troponin 1 as a prognostic biomarker.

The study found that if troponin 1 levels were above a certain threshold in the blood (0.03ng/ml), there was an increased risk of neurological deterioration, while troponin levels below the threshold predicted a much lower risk. This observation could even predict neurological deterioration at low NIHSS scores, where NIHSS had a more favorable prognosis. It did not have enough evidence to be used as a solo marker but has the potential to be used in combination with clinical indicators already in place.

Biomarkers have been a significant area of research in recent years, with many useful biomarkers for cancer and other diseases identified every year. Cardiovascular biomarkers have been more of a challenge to identify, but troponin 1 has shown itself to be a great indicator of prognosis after a stroke or heart attack. This study showed troponin 1 could even be used to predict neurological damage, which could help patients and doctors get ahead of the problem faster than with clinical indicators alone.

The study concludes, “even slight increases in cTnI should be cautiously interpreted and the patients need close observation. However, our insights must be validated with further large, prospective studies.”

Sources: Nature Scientific Reports, Duke Clinical Research Institute

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
FEB 18, 2021
Cardiology
Ongoing Heart Problems in Discharged COVID-19 Patients
FEB 18, 2021
Ongoing Heart Problems in Discharged COVID-19 Patients
About 50 percent of patients that are discharged from the hospital after recovering from a severe case of COVID-19 who e ...
APR 01, 2021
Health & Medicine
Flavanol-rich Foods Protect Heart from Stress
APR 01, 2021
Flavanol-rich Foods Protect Heart from Stress
Drinking hot cocoa is comforting on cold winter nights, and new research from the University of Birmingham shows that it ...
MAY 18, 2021
Clinical & Molecular DX
A Crystal Ball for Predicting Labor Day
MAY 18, 2021
A Crystal Ball for Predicting Labor Day
Expectant mothers may no longer have to be caught off guard—researchers have identified biomarkers in the blood th ...
JUL 07, 2021
Cardiology
Wealth Changes Linked to Heart Health Differences
JUL 07, 2021
Wealth Changes Linked to Heart Health Differences
Changes in a person's financial state have been recognized as a major cause of stress . Now researchers have found inves ...
JUL 15, 2021
Drug Discovery & Development
The genomics of high blood pressure - a road to the future of treatment
JUL 15, 2021
The genomics of high blood pressure - a road to the future of treatment
The human heart begins to beat in utero in the early weeks of development and continues throughout life. In an average l ...
AUG 24, 2021
Health & Medicine
Cannabis Use and Cardiovascular Disease- A Lesson in Causality
AUG 24, 2021
Cannabis Use and Cardiovascular Disease- A Lesson in Causality
As the march toward legalization of Marijuana use continues amidst ongoing debate, more attention has been paid to the i ...
Loading Comments...